Literature DB >> 34172566

Mechanistic basis for receptor-mediated pathological α-synuclein fibril cell-to-cell transmission in Parkinson's disease.

Shengnan Zhang1, Yu-Qing Liu2, Chunyu Jia1,3, Yeh-Jun Lim2, Guoqin Feng4,5, Enquan Xu6,7, Houfang Long1,3, Yasuyoshi Kimura6,7, Youqi Tao8, Chunyu Zhao1,3, Chuchu Wang1,3, Zhenying Liu1,3, Jin-Jian Hu2, Meng-Rong Ma2, Zhijun Liu9, Lin Jiang10, Dan Li8, Renxiao Wang4,5,11, Valina L Dawson6,7,12,13,14, Ted M Dawson15,7,12,14,16, Yan-Mei Li17, Xiaobo Mao15,7, Cong Liu18.   

Abstract

The spread of pathological α-synuclein (α-syn) is a crucial event in the progression of Parkinson's disease (PD). Cell surface receptors such as lymphocyte activation gene 3 (LAG3) and amyloid precursor-like protein 1 (APLP1) can preferentially bind α-syn in the amyloid over monomeric state to initiate cell-to-cell transmission. However, the molecular mechanism underlying this selective binding is unknown. Here, we perform an array of biophysical experiments and reveal that LAG3 D1 and APLP1 E1 domains commonly use an alkaline surface to bind the acidic C terminus, especially residues 118 to 140, of α-syn. The formation of amyloid fibrils not only can disrupt the intramolecular interactions between the C terminus and the amyloid-forming core of α-syn but can also condense the C terminus on fibril surface, which remarkably increase the binding affinity of α-syn to the receptors. Based on this mechanism, we find that phosphorylation at serine 129 (pS129), a hallmark modification of pathological α-syn, can further enhance the interaction between α-syn fibrils and the receptors. This finding is further confirmed by the higher efficiency of pS129 fibrils in cellular internalization, seeding, and inducing PD-like α-syn pathology in transgenic mice. Our work illuminates the mechanistic understanding on the spread of pathological α-syn and provides structural information for therapeutic targeting on the interaction of α-syn fibrils and receptors as a potential treatment for PD.

Entities:  

Keywords:  Parkinson’s disease; cell-to-cell transmission; posttranslational modification; α-synuclein

Mesh:

Substances:

Year:  2021        PMID: 34172566      PMCID: PMC8256039          DOI: 10.1073/pnas.2011196118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  55 in total

1.  Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease.

Authors:  Jeffrey H Kordower; Yaping Chu; Robert A Hauser; Thomas B Freeman; C Warren Olanow
Journal:  Nat Med       Date:  2008-04-06       Impact factor: 53.440

2.  Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice.

Authors:  Kelvin C Luk; Victoria Kehm; Jenna Carroll; Bin Zhang; Patrick O'Brien; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2012-11-16       Impact factor: 47.728

3.  Prion-like Propagation of α-Synuclein Is Regulated by the FcγRIIB-SHP-1/2 Signaling Pathway in Neurons.

Authors:  Yu Ree Choi; Seon-Heui Cha; Seo-Jun Kang; Jae-Bong Kim; Ilo Jou; Sang Myun Park
Journal:  Cell Rep       Date:  2018-01-02       Impact factor: 9.423

4.  Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry.

Authors:  H Braak; D Sandmann-Keil; W Gai; E Braak
Journal:  Neurosci Lett       Date:  1999-04-09       Impact factor: 3.046

5.  Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein.

Authors:  Katerina E Paleologou; Adrian W Schmid; Carla C Rospigliosi; Hai-Young Kim; Gonzalo R Lamberto; Ross A Fredenburg; Peter T Lansbury; Claudio O Fernandez; David Eliezer; Markus Zweckstetter; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2008-03-14       Impact factor: 5.157

6.  The Effect of Fragmented Pathogenic α-Synuclein Seeds on Prion-like Propagation.

Authors:  Airi Tarutani; Genjiro Suzuki; Aki Shimozawa; Takashi Nonaka; Haruhiko Akiyama; Shin-Ichi Hisanaga; Masato Hasegawa
Journal:  J Biol Chem       Date:  2016-07-05       Impact factor: 5.157

7.  Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice.

Authors:  Mantia Karampetsou; Mustafa T Ardah; Maria Semitekolou; Alexia Polissidis; Martina Samiotaki; Maria Kalomoiri; Nour Majbour; Georgina Xanthou; Omar M A El-Agnaf; Kostas Vekrellis
Journal:  Sci Rep       Date:  2017-11-28       Impact factor: 4.379

8.  C-terminal α-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease.

Authors:  Ryan P McGlinchey; Shannon M Lacy; Katherine E Huffer; Nahid Tayebi; Ellen Sidransky; Jennifer C Lee
Journal:  J Biol Chem       Date:  2019-05-15       Impact factor: 5.157

9.  Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism.

Authors:  Stanley B Prusiner; Amanda L Woerman; Daniel A Mordes; Joel C Watts; Ryan Rampersaud; David B Berry; Smita Patel; Abby Oehler; Jennifer K Lowe; Stephanie N Kravitz; Daniel H Geschwind; David V Glidden; Glenda M Halliday; Lefkos T Middleton; Steve M Gentleman; Lea T Grinberg; Kurt Giles
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-31       Impact factor: 11.205

10.  Native α-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2.

Authors:  Jiajie Diao; Jacqueline Burré; Sandro Vivona; Daniel J Cipriano; Manu Sharma; Minjoung Kyoung; Thomas C Südhof; Axel T Brunger
Journal:  Elife       Date:  2013-04-30       Impact factor: 8.140

View more
  14 in total

1.  LAG3 ectodomain structure reveals functional interfaces for ligand and antibody recognition.

Authors:  Qianqian Ming; Daiana P Celias; Chao Wu; Aidan R Cole; Srishti Singh; Charlotte Mason; Shen Dong; Timothy H Tran; Gaya K Amarasinghe; Brian Ruffell; Vincent C Luca
Journal:  Nat Immunol       Date:  2022-06-27       Impact factor: 31.250

Review 2.  Conformational strains of pathogenic amyloid proteins in neurodegenerative diseases.

Authors:  Dan Li; Cong Liu
Journal:  Nat Rev Neurosci       Date:  2022-05-30       Impact factor: 38.755

3.  α-Synuclein fibril-specific nanobody reduces prion-like α-synuclein spreading in mice.

Authors:  Yemima R Butler; Yuqing Liu; Ramhari Kumbhar; Peiran Zhao; Kundlik Gadhave; Ning Wang; Yanmei Li; Xiaobo Mao; Wenjing Wang
Journal:  Nat Commun       Date:  2022-07-19       Impact factor: 17.694

Review 4.  Alpha-Synuclein Aggregation Pathway in Parkinson's Disease: Current Status and Novel Therapeutic Approaches.

Authors:  Marija Vidović; Milena G Rikalovic
Journal:  Cells       Date:  2022-05-24       Impact factor: 7.666

Review 5.  Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexity.

Authors:  Stephanie E A Burnell; Lorenzo Capitani; Bruce J MacLachlan; Georgina H Mason; Awen M Gallimore; Andrew Godkin
Journal:  Immunother Adv       Date:  2021-12-20

6.  Characterization of a Novel Monoclonal Antibody for Serine-129 Phosphorylated α-Synuclein: A Potential Application for Clinical and Basic Research.

Authors:  Weijin Liu; Qidi Zhang; Hao Xing; Ge Gao; Jia Liu; Yue Huang; Hui Yang
Journal:  Front Neurol       Date:  2022-02-17       Impact factor: 4.003

Review 7.  Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies.

Authors:  Roberta Cascella; Alessandra Bigi; Nunilo Cremades; Cristina Cecchi
Journal:  Cell Mol Life Sci       Date:  2022-03-04       Impact factor: 9.207

8.  The small aromatic compound SynuClean-D inhibits the aggregation and seeded polymerization of multiple α-synuclein strains.

Authors:  Samuel Peña-Díaz; Jordi Pujols; Eftychia Vasili; Francisca Pinheiro; Jaime Santos; Zoe Manglano-Artuñedo; Tiago F Outeiro; Salvador Ventura
Journal:  J Biol Chem       Date:  2022-04-04       Impact factor: 5.486

Review 9.  α-Synuclein Conformational Plasticity: Physiologic States, Pathologic Strains, and Biotechnological Applications.

Authors:  Amanda Li; Cyrus Rastegar; Xiaobo Mao
Journal:  Biomolecules       Date:  2022-07-17

10.  Hypoxia and Alpha-Synuclein: Inextricable Link Underlying the Pathologic Progression of Parkinson's Disease.

Authors:  Mengyuan Guo; Xunming Ji; Jia Liu
Journal:  Front Aging Neurosci       Date:  2022-07-26       Impact factor: 5.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.